fludarabine phosphate has been researched along with Erythroderma, Sezary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernengo, MG; Fierro, MT; Quaglino, P; Rossotto, GL; Savoia, P | 1 |
| Nikko, AP; Pandya, AG; RutherFord, CJ | 1 |
2 other study(ies) available for fludarabine phosphate and Erythroderma, Sezary
| Article | Year |
|---|---|
Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Antimetabolites, Antineoplastic; Cohort Studies; Female; Humans; Lymphocyte Subsets; Male; Middle Aged; Mycosis Fungoides; Phenotype; Photopheresis; Pilot Projects; Sezary Syndrome; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vidarabine Phosphate | 2004 |
Successful treatment of Sézary syndrome with lymphomatous transformation to large cell lymphoma with fludarabine phosphate.
Topics: Aged; Antimetabolites, Antineoplastic; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Sezary Syndrome; Skin Neoplasms; Vidarabine Phosphate | 1996 |